To test the validity of an augmented tuberculosis skin test (a‐TST) combined with Quantiferon TB‐gold® (QFTG) test for the screening of latent tuberculosis infection (LTBI) in patients with rheumatoid arthritis… Click to show full abstract
To test the validity of an augmented tuberculosis skin test (a‐TST) combined with Quantiferon TB‐gold® (QFTG) test for the screening of latent tuberculosis infection (LTBI) in patients with rheumatoid arthritis (RA) being considered for treatment with biologic disease‐modifying anti‐rheumatic drugs or targeted synthetic disease‐modifying anti‐rheumatic drugs.
               
Click one of the above tabs to view related content.